scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1085406785 |
P356 | DOI | 10.1007/S10549-017-4287-4 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10549-017-4287-4 |
P932 | PMC publication ID | 5510603 |
P698 | PubMed publication ID | 28503721 |
P50 | author | Jenny Chang-Claude | Q21263057 |
Muhammad G Kibriya | Q56125220 | ||
John Hopper | Q56726496 | ||
Esther M. John | Q59752419 | ||
Irene L Andrulis | Q64516140 | ||
Habibul Ahsan | Q71040112 | ||
Maria Argos | Q71040248 | ||
Mary Beth Terry | Q75067963 | ||
Molly Scannell Bryan | Q85667683 | ||
Dezheng Huo | Q89094846 | ||
Mary B. Daly | Q96105692 | ||
Jeanine M Genkinger | Q100394514 | ||
Marilie Gammon | Q104751082 | ||
Saundra S. Buys | Q109562977 | ||
Kathleen E. Malone | Q110376035 | ||
Farzana Jasmine | Q114337547 | ||
Olofunmilayo I Olopade | Q114435377 | ||
P2093 | author name string | Lin Chen | |
P2860 | cites work | Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 |
A global reference for human genetic variation | Q25909434 | ||
An Integrated Genome-Wide Systems Genetics Screen for Breast Cancer Metastasis Susceptibility Genes | Q27308942 | ||
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study | Q28075560 | ||
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations | Q28388475 | ||
The GenABEL Project for statistical genomics | Q28600877 | ||
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese | Q28943542 | ||
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. | Q29417036 | ||
GCTA: a tool for genome-wide complex trait analysis | Q29547216 | ||
GenABEL: an R library for genome-wide association analysis | Q29614587 | ||
A general framework for estimating the relative pathogenicity of human genetic variants | Q29615730 | ||
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer | Q33566957 | ||
Poly-omic prediction of complex traits: OmicKriging | Q33812687 | ||
Application status of tamoxifen in endocrine therapy for early breast cancer | Q35758139 | ||
Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study | Q35815602 | ||
Is breast cancer prognosis inherited? | Q35906350 | ||
Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies | Q36152947 | ||
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. | Q36479375 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis | Q37261038 | ||
Personalizing breast cancer staging by the inclusion of ER, PR, and HER2. | Q38168732 | ||
Personalized therapy for breast cancer | Q38196466 | ||
Pharmacogenomics toward personalized tamoxifen therapy for breast cancer | Q38364888 | ||
Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study | Q39006292 | ||
Cancer Statistics, 2017. | Q39038674 | ||
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States | Q39734134 | ||
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women | Q40379855 | ||
Survival time according to the year of recurrence and subtype in recurrent breast cancer | Q41650346 | ||
Factors used to select adjuvant therapy of breast cancer in the United States: an overview of age, race, and socioeconomic status. | Q43843528 | ||
Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases | Q44438551 | ||
Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 ( | Q46340590 | ||
Familial concordance in cancer survival: a Swedish population-based study | Q47573086 | ||
One step at a time: CYP2D6 guided tamoxifen treatment awaits convincing evidence of clinical validity. | Q53088506 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | whole genome sequencing | Q2068526 |
genetic variation | Q349856 | ||
P304 | page(s) | 707-717 | |
P577 | publication date | 2017-05-13 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction | |
P478 | volume | 164 |
Search more.